Boston Scientific Announces February and March 2021 Conference Schedule
Get Alerts BSX Hot Sheet
Join SI Premium – FREE
MARLBOROUGH, Mass., Feb. 12, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences.
On February 25, 2021, Dan Brennan, executive vice president and chief financial officer, and Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question-and-answer session with the host analyst at the virtual SVB Leerink 10th Annual Global Healthcare Conference. The session will begin at approximately 10:40 a.m. EST.
On March 1, 2021, Meghan Scanlon, senior vice president and president, Urology and Pelvic Health, and Susie Lisa will participate in a 30-minute question-and-answer session with the host analyst at the virtual Cowen 41st Annual Health Care Conference. The session will begin at approximately 2 p.m. EST.
A live webcast and replay of the webcast for each event will be accessible at investors.bostonscientific.comhttp://www.bostonscientific.com/investors. The replay will be available beginning approximately one hour following the completion of each event.
About Boston ScientificBoston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.
CONTACTS | |
Media: | Investors: |
Katie Schur | Susie Lisa, CFA |
508-683-5574 (office) | 508-683-5565 (office) |
Media Relations | Investor Relations |
Boston Scientific Corporation | Boston Scientific Corporation |
View original content to download multimedia:http://www.prnewswire.com/news-releases/boston-scientific-announces-february-and-march-2021-conference-schedule-301227326.html
SOURCE Boston Scientific Corporation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Zhejiang Wenda Pharma Announces Positive Results from Phase II Trial of Oral BET Inhibitor NHWD-870 HCl at the 2026 ESMO Annual Meeting
- ADA Price Prediction: Cardano Opens Its Dijkstra Testnet at $0.22, While Pepeto Buyers Chase a Pepe Repeat
- Herman Law Client Survivors Reach Landmark Settlement With Archdiocese of New York
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Twitter, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share